Marijuana Stocks Not Getting Investors High Ahead of Earnings

After growing like a weed last year, marijuana stocks have gone up in smoke so far in 2019.

After growing like a weed last year, marijuana stocks have gone up in smoke so far in 2019.

Excusing the puns, it’s been a brutal couple of quarters for Canadian marijuana stocks. After last year’s surging interest in the nascent industry, investors’ expectations were impossibly high; as the reality of selling an easy-to-grow plant (it’s called “weed” for a reason!) in a heavily-regulated industry sunk in, traders have become increasingly disillusioned with the outlook for these firms, many of which have yet to reach profitability.

Source: TradingView, City Index

That said, the potential market remains compelling and valuations for industry bellwethers are at 2-year lows, leading the investment bank Cantor Fitzgerald to come out bullish on the sector last week. One catalyst that could boost leading marijuana stocks as they report earnings this week is heavy short positioning, which could lead to classic “short squeeze” setups on better-than-expected results in the following firms:

  • Cronos (CRON) – 26% of float held short
  • Tilray (TLRY) – 38% of float held short
  • Aurora Cannabis (ACB) – 19% of float held short
  • Canopy Growth (CGC) – 25% of float held short

Below, we highlight some key factors to watch as each of these firms report earnings this week:

1)     Cronos (CRON) – Narrower Loss, Miss on Revenues

While Cronos has a relatively small footprint compared to its peers, with minimal presence even in domestic provinces like Quebec and Alberta, it has benefitted from a massive $1.8B investment from Altria Group. The firm just reported -$0.02 in EPS, beating estimates of a -$0.03 loss, though revenues came in lighter than expected at $10.1M. Traders are nonplussed at first glance, with the stock trading down -3% in early trade today.

Given the firm’s small footprint and major corporate backer, CRON represents one of the highest upside plays in the sector moving forward, albeit with substantial risk as it tries to overcome rivals’ early mover advantages.

2)     Tilray (TLRY) – Elevated Inventories May Weigh on Last Year’s Highest Flyer

Tilray garnered top billing around this time last year when the stock surged from around $20 to peak near $300 in about five weeks. Since that mini-bubble though, Tilray has been the worst performing stock in the sector, completing its round trip back to $20 last month. Looking ahead to this afternoon’s earnings report, the key factor to watch will be inventories, which are expected to remain elevated, especially for retail clients. Analysts are expecting a -$0.30 loss per share on sales of $49M.

3)     Aurora Cannabis (ACB) – Profitability Dreams Delayed

Aurora was one of the first movers among Canadian cannabis firms, but the company has yet to reach profitability. The firm had initially sought to get into the black in the fourth quarter, but that goal looks increasingly remote as new entrants have increased the supply (and therefore driven down the price) of the commodity. Analysts are looking for a loss of -$0.05 per share on revenues of $90M in Thursday afternoon’s earnings report.

4)     Canopy Growth (CGC) – Poised to Capitalize on CannTrust’s Troubles

The world’s largest marijuana company by market capitalization may be best positioned heading into this week’s earnings reports. Rival CannTrust Holdings halted all sales after it was revealed to be growing in unlicensed rooms, potentially opening the door for Canopy Growth to capitalize on medical patients looking for a new provider. For the CGC mothership, analysts are looking for a loss of -$0.41 per share on $101.5M in sales Thursday morning, but it will also be worth watching results from Acreage Holdings this afternoon, which CGC has the right to buy if marijuana is fully legalized in the US.

With these industry leaders (and a swath of second-tier producers) all reporting this week, traders will soon have a better idea on whether the industry is poised for a second phase of “weed-like” growth or whether the current downtrend will extend into 2020.


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

StoneX Financial Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.